Thermo Fisher extends SARS-CoV-2 global access sequencing programme
Thermo Fisher's next-generation sequencing (NGS) technology offers researchers fast, real-time sequencing-data acquisition and easy data sharing across the global scientific community, as suggested by the US Food and Drug Administration (FDA) and European Centre for Disease Prevention and Control (ECDC)
United Kingdom Garret Hampton Drug Administration Globalaccess Sequencing Programme European Centre For Disease Prevention Thermo Fisher
Source: biospectrumindia.com